All information included will be updated as needed as this continues to be a rapidly changing situation. It is your responsibility to be aware of the current information if you attend an event.
Click here to view Requirements and Guidelines. Today there are instructors in nearly every state of the country, as well as several internationally. Read the full article here. Kristy Richards, M. About 6 million dogs are diagnosed with cancer each year, and more than half of dogs older than 10 years will develop cancers such as osteosarcoma, lymphoma, or melanoma.
But the heartbreaking diagnosis for dog owners is a treasure trove of potential data for oncology researchers.
In clinical trials at academic research centers across the country, veterinarians and physicians are studying how pet dogs respond to cancer therapies and analyzing the genetic makeup of these tumors.
Although medicine and veterinary medicine, for the most part, have been viewed as two different worlds, with little exchange of information between the two, that is beginning to change. In recognition of the potential utility of canine cancer models, the NCI established COP in to promote comparative oncology research.
And just last year, the National Academy of Medicine held a workshop on comparative oncology and issued a report addressing how to best integrate clinical trials of pets with naturally occurring cancers into human oncology research. The surge in comparative oncology research may be due to a convergence of factors, noted Will Eward, DVM, MD, an assistant professor of orthopaedic surgery at Duke University School of Medicine, who researches and treats sarcoma in both human and furry, four-legged canine patients.
Canine clinical trials in progress or completed are already demonstrating the value of comparative oncology. Clinical Research Trial Overview Clinical trials may involve novel diagnostic methods or therapies including chemotherapy, radiation therapy, surgical procedures, hypo- or hyperthermia, immunotherapy and photodynamic therapy, among others. Reminder for veterinarians managing pets enrolled in clinical trials Adherence to the treatment protocol is of vital importance to ensure that the protocol is followed as planned, such that the results are both reliable and meaningful.
For most trials, owners are asked to agree to a necropsy in the event of the death of their pet. Pet owners also may appreciate the translational value of the research in which their pet may be participating.
Many naturally-occurring cancers in pet animals closely resemble human cancer and provide meaningful systems for cancer research to benefit both man and animals. The clinical trials listed on this website are not run under the auspices of the Veterinary Cancer Society.
While the hope is that the investigators will find a less toxic or more effective treatment for cancer, there are no guarantees regarding the outcome of any trials listed on clinical searchable database found on this site.
0コメント